New Delhi: Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan will dedicate India’s first indigenous H5N1 chicken vaccine to the nation on 20 November 2026. The event will take place at ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal. The vaccine targets the highly pathogenic avian influenza (HPAI) virus of Clade 2.3.2.1a.
ICAR-NIHSAD developed the inactivated vaccine indigenously. It is the first Indian vaccine designed to protect chickens against the H5N1 HPAI virus of this specific clade. The development addresses the need for a domestic vaccine against strains circulating in the country.
Highly pathogenic avian influenza, commonly known as bird flu, poses a serious threat to poultry. Outbreaks can cause nearly 100 per cent mortality among infected birds. Consequently, poultry farmers face heavy losses from bird culling and trade restrictions. The disease can also affect international trade, poultry product prices and farmers’ livelihoods.
India first detected the disease in 2006. Since then, the country has reported more than 500 combined outbreaks involving the H5N1 and H5N8 subtypes. The scale of these outbreaks highlights the economic risks posed by bird flu.
H5N1 chicken vaccine targets a major poultry threat
A major bird flu outbreak could reduce India’s GDP growth by up to 1.5 per cent. More than 20 per cent of the country’s poultry population could also face risk if the disease spreads without control. The 2006 outbreak caused estimated direct and indirect losses of Rs. 2,200–3,000 crore. In Manipur, an outbreak resulted in losses equal to 0.5 per cent of the state’s GDP.
Bird flu also raises public health concerns. The World Health Organization has reported 1,003 human H5N1 cases across 25 countries, including India, since 2003. These cases included 479 deaths.
Studies have identified H5N1 Clade 2.3.2.1a as the strain responsible for most bird flu outbreaks in chickens. More recently, infections involving this strain have appeared in different animal species, including mammals. Three human cases have also been detected.
Therefore, controlling the virus is important for protecting poultry farms and limiting its spread to other animals and humans. However, no specific commercial vaccine is currently available against H5N1 Clade 2.3.2.1a. The indigenous vaccine developed by ICAR-NIHSAD aims to fill this gap by protecting against the strains circulating in India.